Chase Investment Counsel’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Hold
70,000
0.34% 62
2026
Q1
$1.63M Hold
70,000
0.43% 55
2025
Q4
$1.4M Hold
70,000
0.39% 59
2025
Q3
$1.28M Hold
70,000
0.38% 61
2025
Q2
$1.41M Hold
70,000
0.45% 56
2025
Q1
$1.27M Sell
70,000
-10,000
-13% -$179K 0.46% 58
2024
Q4
$1.39M Hold
80,000
0.45% 54
2024
Q3
$1.54M Hold
80,000
0.51% 52
2024
Q2
$1.31M Buy
80,000
+6,000
+8% +$93.1K 0.47% 55
2024
Q1
$1.13M Buy
74,000
+6,000
+9% +$94.2K 0.42% 66
2023
Q4
$1.09M Buy
+68,000
New +$951K 0.48% 57
2019
Q1
Sell
-21,155
Closed -$369K 106
2018
Q4
$369K Buy
+21,155
New +$344K 0.22% 70

Other funds holding INVA

Chase Investment Counsel's INVA Position: Q2 2026 in Review

Chase Investment Counsel held its Innoviva (INVA) position steady in Q2 2026 at 70,000 shares worth $1.59M. The position accounts for 0.34% of the portfolio, ranked #62.

Chase Investment Counsel first reported a position in INVA in Q4 2018 and has held it in 12 quarters since. The position peaked at $1.63M in Q1 2026. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Chase Investment Counsel held 70,000 shares of Innoviva worth $1.59M as of Q2 2026.
  • Chase Investment Counsel left its Innoviva share count unchanged in Q2 2026.
  • Innoviva made up 0.34% of Chase Investment Counsel's portfolio in Q2 2026, its #62 holding.
  • Chase Investment Counsel first reported a position in Innoviva in Q4 2018 and has held it in 12 quarters since.
  • Chase Investment Counsel's Innoviva position peaked at $1.63M in Q1 2026.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Chase Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.